Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xsphera Biosciences
Cambridge/Boston*, Massachusetts, United Statesxspherabio.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Xsphera Biosciences has developed an ex vivo human tumor tissue-based testing platform that enables direct assessment of therapeutic efficacy across diverse cancer indications and drug modalities. Their technology preserves the patient’s unique tumor microenvironment within microfluidic devices, allowing multi-modal analysis of immune-mediated responses. The system is integrated with an AI-driven cloud analytics suite for deep mechanistic insights into response and resistance. The company collaborates with leading pharma/biotech clients globally, supporting translational research from preclinical through early clinical development.
- Therapeutic areas
- Oncology
- Modalities
- BiologicSmall moleculeMonoclonal antibodyBispecific monoclonal antibodyAntibody-drug conjugateOncolytic virus therapy
- Industry
- Biotech
02
Partnerships
Dana-Farber Cancer Institute (exclusive technology license)NEX-I (collaboration on immune-oncology therapeutics evaluation; NXI–101 program)
Beyond the preview
Go deeper on Xsphera Biosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xsphera Biosciences.